Accumulating studies suggest that hepatic MDA and ROS levels are significantly increased, while some anti-oxidative stress proteins including GSH-Px and SOD levels are significantly declined in NAFLD patients 42-45. Here, SOD1 is linked to metabolic dysfunction-associated steatotic liver disease.